STOCK TITAN

Monogram Technologies to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday, March 12, 2025 at 4:30 p.m. Eastern Time

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Monogram Technologies (NASDAQ:MGRM), an AI-driven robotics company specializing in orthopedic surgery, has scheduled its Q4 and Full Year 2024 financial results conference call for March 12, 2025, at 4:30 p.m. Eastern Time. The event will feature CEO Ben Sexson and CFO Noel Knape, who will present the company's financial performance for the period ending December 31, 2024, along with regulatory updates and key milestones.

A detailed press release will be issued before the call, and the presentation will be accessible through the company's investor relations website. Participants can join the webcast through the provided StreamYard link, with a Q&A session following the main presentation.

Monogram Technologies (NASDAQ:MGRM), un'azienda di robotica guidata dall'IA specializzata nella chirurgia ortopedica, ha programmato la sua call sui risultati finanziari del Q4 e dell'anno intero 2024 per il 12 marzo 2025, alle 16:30 ora orientale. L'evento vedrà la partecipazione del CEO Ben Sexson e del CFO Noel Knape, che presenteranno le performance finanziarie dell'azienda per il periodo che termina il 31 dicembre 2024, insieme ad aggiornamenti normativi e traguardi chiave.

Un comunicato stampa dettagliato sarà emesso prima della call, e la presentazione sarà accessibile tramite il sito web delle relazioni con gli investitori dell'azienda. I partecipanti potranno unirsi al webcast attraverso il link StreamYard fornito, con una sessione di domande e risposte dopo la presentazione principale.

Monogram Technologies (NASDAQ:MGRM), una empresa de robótica impulsada por IA especializada en cirugía ortopédica, ha programado su llamada de resultados financieros del Q4 y del año completo 2024 para el 12 de marzo de 2025, a las 4:30 p.m. hora del Este. El evento contará con la participación del CEO Ben Sexson y del CFO Noel Knape, quienes presentarán el rendimiento financiero de la empresa para el período que finaliza el 31 de diciembre de 2024, junto con actualizaciones regulatorias y hitos clave.

Se emitirá un comunicado de prensa detallado antes de la llamada, y la presentación estará disponible a través del sitio web de relaciones con inversores de la empresa. Los participantes podrán unirse al webcast a través del enlace de StreamYard proporcionado, con una sesión de preguntas y respuestas tras la presentación principal.

모노그램 테크놀로지스 (NASDAQ:MGRM)는 정형외과 수술 전문의 AI 기반 로봇 회사로, 2024년 4분기 및 연간 재무 결과 발표 전화회의2025년 3월 12일 오후 4시 30분 동부 표준시에 예정하고 있습니다. 이 행사에는 CEO 벤 섹슨과 CFO 노엘 크네이프가 참석하여 2024년 12월 31일 기준으로 하는 기간 동안의 회사 재무 성과와 규제 업데이트, 주요 이정표를 발표할 예정입니다.

전화회의 전에 자세한 보도 자료가 발표될 예정이며, 발표 자료는 회사의 투자자 관계 웹사이트를 통해 접근할 수 있습니다. 참가자들은 제공된 StreamYard 링크를 통해 웹캐스트에 참여할 수 있으며, 주요 발표 후에는 Q&A 세션이 진행됩니다.

Monogram Technologies (NASDAQ:MGRM), une entreprise de robotique alimentée par l'IA spécialisée dans la chirurgie orthopédique, a programmé sa conférence téléphonique sur les résultats financiers du T4 et de l'année complète 2024 pour le 12 mars 2025 à 16h30 heure de l'Est. L'événement mettra en vedette le PDG Ben Sexson et le CFO Noel Knape, qui présenteront les performances financières de l'entreprise pour la période se terminant le 31 décembre 2024, ainsi que des mises à jour réglementaires et des jalons clés.

Un communiqué de presse détaillé sera publié avant l'appel, et la présentation sera accessible via le site Web des relations avec les investisseurs de l'entreprise. Les participants pourront rejoindre le webcast via le lien StreamYard fourni, suivi d'une session de questions-réponses après la présentation principale.

Monogram Technologies (NASDAQ:MGRM), ein KI-gesteuertes Robotikunternehmen, das auf orthopädische Chirurgie spezialisiert ist, hat seine Konferenzschaltung zu den finanziellen Ergebnissen des Q4 und des gesamten Jahres 2024 für den 12. März 2025 um 16:30 Uhr Eastern Time angesetzt. Bei der Veranstaltung werden CEO Ben Sexson und CFO Noel Knape anwesend sein, die die finanzielle Leistung des Unternehmens für den Zeitraum bis zum 31. Dezember 2024 sowie regulatorische Updates und wichtige Meilensteine präsentieren werden.

Vor der Konferenz wird eine detaillierte Pressemitteilung veröffentlicht, und die Präsentation wird über die Investor-Relations-Website des Unternehmens zugänglich sein. Die Teilnehmer können über den bereitgestellten StreamYard-Link an dem Webcast teilnehmen, gefolgt von einer Fragerunde nach der Hauptpräsentation.

Positive
  • None.
Negative
  • None.

AUSTIN, TX / ACCESS Newswire / February 27, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, will hold a conference call webcast on Wednesday, March 12, 2025 at 4:30 p.m. Eastern Time in conjunction with its reported financial results for the fourth quarter and full fiscal year ended December 31, 2024, and to discuss regulatory updates and key milestones. A press release detailing these results will be issued prior to the call.

Monogram CEO Ben Sexson and CFO Noel Knape will host the conference call webcast, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company's website here.

To access the call, please use the following information:

Date: Wednesday, March 12, 2025

Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)

Registration Link: https://streamyard.com/watch/MHCyeqvkPqzK

The conference call webcast will be broadcast live and available for replay at the investor relations section of the Company's website here.

Forward-Looking Statements

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties.. Forward-looking statements, other than statements of historical fact, are highly likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under our control, and that the Company may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from any forward-looking statements as a result of a number of factors, including those described in the prospectus and the Company's other filings with the SEC. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Investor Relations

Chris Tyson
Executive Vice President
MZ North America
Direct: 949-491-8235
MGRM@mzgroup.us

SOURCE: Monogram Technologies Inc.



View the original press release on ACCESS Newswire

FAQ

When will Monogram Technologies (MGRM) release its Q4 2024 earnings?

Monogram Technologies will release Q4 and Full Year 2024 earnings on March 12, 2025, with results announced via press release before the conference call at 4:30 p.m. ET.

How can investors access MGRM's Q4 2024 earnings call?

Investors can access the conference call webcast through StreamYard using the registration link provided or through the investor relations section of Monogram's website.

Who will be presenting at Monogram Technologies' Q4 2024 earnings call?

CEO Ben Sexson and CFO Noel Knape will host the conference call and presentation, followed by a Q&A session.

What topics will be covered in MGRM's upcoming earnings call?

The call will cover Q4 and FY2024 financial results, regulatory updates, and key milestones for the AI-driven orthopedic surgery robotics company.

Monogram Orthopaedics Inc

NASDAQ:MGRM

MGRM Rankings

MGRM Latest News

MGRM Stock Data

76.52M
22.28M
34.22%
3.85%
0.81%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
BROOKLYN